QualityStocksNewsBreaks Archives - Page 741 of 1476

WednesdayMay 05, 2021 1:38 pm

QualityStocksNewsBreaks – InvestorBrandNetwork Achieves Incredible 2021 Growth Metrics, to Actively Build on Momentum

InvestorBrandNetwork (“IBN”), an innovative corporate communications agency and diversified content distributor, today announced significant growth milestones it has achieved in early 2021. Since the launch of the first brand of its communications platform in 2006, IBN has consistently attained transformative growth. Today, the IBN Investor Brand Platform comprises a portfolio of 50+ brands with a collective social media audience that includes millions of followers and an expansive network of 5,000+ key syndication partners. IBN’s unique value proposition for companies operating across a broad array of industries is demonstrated by its proven track record serving 500+ client partners. “IBN is already…

WednesdayMay 05, 2021 12:33 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Eyes Many Exciting Developments for V2 of Fan Pass Platform

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced growth for its Fan Pass platform for the month of April 2021. Now in testing in version 2 of the Fan Pass live streaming platform, the implementation of new onboarding features and technology upgrades will provide artists with near-instant gratification. The company’s live channel activations increased by 2,250% in the month of April 2021 alone, building on the previous month’s success. “The Fan Pass team is hard at work testing every aspect of our version 2 of the Fan Pass Live platform and I believe our current artists, their…

WednesdayMay 05, 2021 12:29 pm

QualityStocksNewsBreaks – TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Provides Update on Beyond Tobacco(TM) Patent Filing

TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) has announced that its Beyond Tobacco(TM) patent filing has advanced to the nonprovisional status. The company submitted the patent filing for its exclusive process that is used to produce Beyond Tobacco’s taste and smell that is similar to tobacco. The filing was submitted to the United States Patent and Trademark Office in September 2020. The patent will protect the refinement technique that characterizes both TAAT(TM) and its Beyond Tobacco base material. The company believes that the patent will prove valuable as the company focuses on establishing a market position and…

WednesdayMay 05, 2021 12:14 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures Centralized IRB Approval for Acclaim-1 Clinical Trial

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced its receipt of centralized Institutional Review Board (“IRB”) approval of the clinical trial protocol for its upcoming Acclaim-1 clinical trial in non-small cell lung cancer (“NSCLC”). Acclaim-1 is an open-label, multi-center Phase 1/2 clinical trial that combines the company’s lead drug candidate, REQORSA(TM) immunogene therapy, with AstraZeneca’s Tagrisso(R) (osimertinib) in patients with late-stage NSCLC with mutated epidermal growth factor receptors (“EGFRs”), whose disease progressed after treatment with Tagrisso. “The purpose of IRB review is to assure that appropriate steps…

WednesdayMay 05, 2021 11:31 am

Current Deficiencies in The Rational Development of CBD-based Wellness Products

Even major players in the CBD market do not offer detailed and verifiable study results to effectively differentiate their products on the basis of meaningful clinical findings, essentially exploiting the “natural” label without any R&D efforts This industry deficiency represents immense opportunities for R&D-driven companies such as Green Hygienics Green Hygienics intends to use its intellectual and capital resources to establish and apply state-of-the-art research and development to a new generation of cannabinoid-based products having specifically assessed health-wellness efficacies CBD Reality Check Interest in the therapeutic use of hemp-derived nonintoxicating cannabinoids, such as cannabidiol (“CBD”) and cannabigerol (“CBG”), has reached…

WednesdayMay 05, 2021 10:25 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) Rail Vision Enters Agreement to Supply Proof-of-Concept Prototype

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that its affiliate, Rail Vision Ltd., has entered an agreement with Hitachi Rail STS Australia Pty Ltd. to supply equipment, services and personnel to the Australian rail company Rio Tinto Railway Network. Under the agreement, Hitachi Rail STS, the project integrator, will provide Rio Tinto with a prototype of Rail Vision’s Collision Avoidance System to undergo demonstration and feasibility testing for a proof-of-concept project. Project revenue is expected to total $265,000, with an option for Rail Vision to furnish additional services for $133,000. To view…

WednesdayMay 05, 2021 10:12 am

QualityStocksNewsBreaks –Splash Beverage Group Inc. (SBEV) Announces Distribution Agreement for SALT Naturally Flavored Tequila

Splash Beverage (OTCQB: SBEV), a holding company with a leading portfolio of beverage brands, has finalized an arrangement with Pepin Distributing for its SALT Naturally Flavored 100% Agave Tequila line. SALT Naturally Flavored Tequila will join the more than 168 premier brands distributed by Pepin Distributing, which is based in Tampa, Florida. Pepin already handles Splash Beverage’s Copa di Vino. SALT Naturally Flavored Tequila is 100% agave, 80 proof naturally flavored tequila that is grown, distilled and battled in Mexico. Every bottle of smooth SALT Tequila, which is available in a variety of natural flavors including Berry, Citrus and Salted Chocolate,…

WednesdayMay 05, 2021 9:45 am

QualityStocksNewsBreaks – Sanwire Corp.’s (SNWR) Intercept Music Signs Godsize Records

Sanwire (OTC: SNWR), a diversified company with a focus on technologies for the entertainment industry, together with its 100% wholly owned subsidiary, Intercept Music Inc., today announced the signing of Godsize Records to its Label Incubator Program. According to the update, Godsize Records is a blooming new upstart label that focuses on new rock talent based in the United States. "Godsize Records is a great addition to our Label Incubator Program, and we see many synergies between the companies," said Tod Turner, president of Intercept Music. "We are excited to help them develop their artists with our industry first products…

WednesdayMay 05, 2021 9:43 am

QualityStocksNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Share FusionOne Waste to Power Tech Update

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, earlier invested in FusionOne Energy Corp. and recently shared an update on that investment. FusionOne is a private, end-to-end technology and operations company specializing in renewable electricity, white hydrogen production and thermal processing technologies. The company has created technology designed for the conversion of plastic waste to hydrogen and clean electricity. According to the update, FusionOne’s fabrication facility has begun production of the HydroPlas continuous cycle reactor, a key component of FusionOne’s efficient hydrogen-producing system. The reactor, along with other supporting proprietary technologies are slated for a Q3…

TuesdayMay 04, 2021 4:21 pm

QualityStocksNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Appoints Proven Pharmaceutical Exec as Chief Commercial Officer

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, today announced the appointment of Ann Cunningham as its chief commercial officer. Cunningham, who has been and will continue serving on VTGN’s board of directors, has a proven pharmaceutical commercial track record of more than 25 years delivering sales, marketing and global life cycle product management expertise in roles across several health care markets, including neuropsychiatry and other CNS markets that VistaGen is pursuing. “Since joining our board, Ann’s…

Site Search

Company Search

Category: QualityStocksNewsBreaks